Dr John S Han, in Norwalk, CA - Pain Medicine

Dr John S Han, is a Pain Medicine - Pain Medicine physician based in Norwalk, California. Dr John S Han is licensed to practice in California (license number C62909B) and his current practice location is 11832 Rosecrans Ave, 2nd Floor, Norwalk, California. He can be reached at his office (for appointments etc.) via phone at (213) 216-3272.

NPI number for Dr John S Han is 1174743603 and his current mailing address is 8706 Hillcrest Cir, Buena Park, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1174743603.

Contact Information

	Dr John S Han,
	11832 Rosecrans Ave, 2nd Floor, Norwalk, CA 90650-4107
	(213) 216-3272
	Not Available

Physician's Profile

Full Name	Dr John S Han
Gender	Male
Speciality	Pain Medicine - Pain Medicine
Location	11832 Rosecrans Ave, Norwalk, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1174743603
Provider Enumeration Date: 04/26/2007
Last Update Date: 03/07/2023

Medical Identifiers

Medical identifiers for Dr John S Han such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1174743603	NPI	-	NPPES
00C429090	Medicaid	CA

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0000X	Pain Medicine - Pain Medicine	C62909B (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John S Han is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John S Han, 8706 Hillcrest Cir, Buena Park, CA 90621-1079 Ph: () -	Dr John S Han, 11832 Rosecrans Ave, 2nd Floor, Norwalk, CA 90650-4107 Ph: (213) 216-3272

News Archive

ARIAD reports data from Iclusig Phase 2 trial in adult patients with gastrointestinal stromal tumors

ARIAD Pharmaceuticals, Inc. today announced, for the first time, data from its Phase 2 trial of Iclusig (ponatinib) in adult patients with refractory metastatic and/or unresectable gastrointestinal stromal tumors (GIST).

Medivation, Astellas enroll 1,199 patients in MDV3100 Phase 3 AFFIRM study in advanced prostate cancer

Medivation, Inc. and Astellas Pharma Inc. today announced that patient enrollment was completed on November 15, 2010 in the Phase 3 AFFIRM study of the investigational drug MDV3100, a novel, triple-acting oral androgen receptor antagonist, in patients with advanced prostate cancer who have previously been treated with chemotherapy. The companies also announced that clinical development of MDV3100 in Japan has commenced, with the initiation of patient dosing in a Phase 1-2 clinical study.

RSV virus selectively kills cancer cells

RSV, a virus that causes respiratory infections in infants and young children, selectively kills cancer cells while leaving healthy cells alone, researchers from the School of Medicine at The University of Texas Health Science Center San Antonio said.

Idiopathic central precocious puberty on the rise in boys

About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.

Dr John S Han, - Pain Medicine in Norwalk, CA